Ensign Peak Advisors’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Sell |
|
|||||
|
2025
Q1 | $1.31M | Hold |
|
|||||
|
2024
Q4 | $1.04M | Hold |
|
|||||
|
2024
Q3 | $1.22M | Hold |
|
|||||
|
2024
Q2 | $937K | Hold |
|
|||||
|
2024
Q1 | $782K | Sell |
|
|||||
|
2023
Q4 | $651K | Hold |
|
|||||
|
2023
Q3 | $474K | Buy |
|
|||||
|
2023
Q2 | $450K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $103K | Buy |
|
|||||
|
2022
Q2 | $84K | Hold |
|
|||||
|
2022
Q1 | $253K | Hold |
|
|||||
|
2021
Q4 | $365K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.49M | Hold |
|
|||||
|
2021
Q1 | $861K | Hold |
|
|||||
|
2020
Q4 | $670K | Sell |
|
|||||
|
2020
Q3 | $732K | Buy |
|